Oramed Pharmaceuticals Inc. (ORMP.TA)

ILA 879.9

(4.22%)

Annual Balance Sheets

(In USD)
Breakdown 2022 2021 2020 2019 2018 2017
Total Assets 568.82 Million 410.07 Million 149.59 Million 122.38 Million 170.6 Million 138.84 Million
Total Current Assets 552.86 Million 305.43 Million 135.78 Million 117.65 Million 111.71 Million 72.79 Million
Cash And Short Term Investments 547.98 Million 301.6 Million 133.73 Million 113.97 Million 109.64 Million 72.08 Million
Cash and Cash Equivalents 142.39 Million 247.47 Million 64.67 Million 11.75 Million 17.98 Million 14.29 Million
Short Term Investments 405.58 Million 54.12 Million 69.05 Million 102.22 Million 91.66 Million 57.78 Million
Net Receivables - - - - - 147.05 Thousand
Inventory - - - - - -
Other Current Assets 4.88 Million 3.83 Million 2.04 Million 3.67 Million 2.06 Million 570.27 Thousand
Total Non-Current Assets 15.95 Million 104.64 Million 13.81 Million 4.72 Million 58.88 Million 66.04 Million
Net PPE 6.34 Million 2.97 Million 583.2 Thousand 84.73 Thousand 61.18 Thousand 64.55 Thousand
Good Will And Intangible Assets - - - - - -
Good Will - - - - - -
Intangible Assets - - - - - -
Long-Term Investments 9.5 Million 101.57 Million 13.16 Million 4.57 Million 58.76 Million 65.93 Million
Tax Assets - - - - - -
Other Non Current Assets 109.08 Thousand 83.29 Thousand 67.03 Thousand 70.61 Thousand 57.59 Thousand 50.21 Thousand
Other Assets 0.00 - - 0.00 - -
Total Liabilities 36.9 Million 36.78 Million 39.39 Million 53.91 Million 58.61 Million 69.84 Million
Total Current Liabilities 20.22 Million 21.39 Million 15.2 Million 18.74 Million 16.38 Million 18.52 Million
Account Payables 7.65 Million 8.34 Million 1.99 Million 4.72 Million 4.08 Million 9.74 Million
Tax Payables - - - - - -
Short Term Debt 869.19 Thousand 416.48 Thousand 147.47 Thousand - - -16.46 Million
Deferred Revenue 4.71 Million 8.65 Million 9.05 Million 9.54 Million 8.81 Million 8.78 Million
Other Current Liabilities 6.98 Million 3.97 Million 4 Million 4.47 Million 3.48 Million -
Total Non Current Liabilities 16.68 Million 15.38 Million 24.19 Million 35.17 Million 42.22 Million 51.32 Million
Long-Term Debt - - - - - -
Deferred Revenue Non Current 14.07 Million 13.59 Million 23.28 Million 34.09 Million 40.98 Million 49.62 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 2.6 Million 1.79 Million 908.32 Thousand 1.07 Million 1.23 Million 1.69 Million
Other Liabilities 0.00 0.00 - - -0.00 -
Total Equity 531.92 Million 373.29 Million 110.2 Million 68.47 Million 111.98 Million 68.99 Million
Stock Holders Equity 534.22 Million 370.9 Million 110.2 Million 68.47 Million 111.98 Million 68.99 Million
Common Stock 1.67 Million 1.35 Million 951.89 Thousand 734.39 Thousand 745.07 Thousand 584.62 Thousand
Retained Earnings -573.88 Million -367.95 Million -310.41 Million -286.35 Million -249.16 Million -202.63 Million
Accumulated other comprehensive income 1.1 Billion 738.86 Million 420.62 Million 354.82 Million 358.61 Million 270.19 Million
Common Stock Equity 534.22 Million 370.9 Million 110.2 Million 68.47 Million 111.98 Million 68.99 Million
Capital Lease Obligation 2.27 Million 1.29 Million 103.9 Thousand - - -
Total Investments 415.08 Million 155.7 Million 82.22 Million 106.79 Million 150.43 Million 123.72 Million
Total Debt 3.14 Million 1.7 Million 251.38 Thousand - - -
Net Debt -139.24 Million -245.76 Million -64.42 Million -11.75 Million -17.98 Million -14.29 Million

Balance Sheet Charts